Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/06/019648
CTRI/2019/06/019648
Recruiting
Phase 4

Evaluation of the utility of genotyping in patients with Budd Chiari Syndrome Versus Standard of care to assess impact on bleeding and costs - A randomized control trial.

Dr Akash Shukla0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Akash Shukla
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Akash Shukla

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who are newly diagnosed for Budd Chiari and are warfarin naive
  • •2\. Aged 18 years to 60 years of either gender
  • •3\. Patients willing to give voluntarily written informed consent
  • •4\. Patient willing to comply with protocol requirements

Exclusion Criteria

  • •1\.Genotype (CYP2C9 and VKORC1\) known to participant from prior testing or available in medical record.
  • •2\.Pregnancy or lactation
  • •3\.Any other clinical condition as per physicianâ??s judgment which compromises safety of the participant or credibility of the data.
  • •4\.Patients with contraindications to warfarin

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of the effect of the genetic polymorphism of drug metabolizing enzyme/transporter and drug interaction on the pharmacokinetics and pharmacodynamics of clopidogrelNot Applicable
KCT0000429Seoul National University18
Completed
Not Applicable
Genotyping and Therapeutic Drug Monitoring in Epileptic patients on Phenytoin : RCTHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
CTRI/2019/09/021317Dr Nithya Gogtay50
Completed
Not Applicable
Genotyping and TDM in Epileptic patients on CBZ : RCTHealth Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
CTRI/2019/09/021311Dr Nithya Gogtay50
Recruiting
Not Applicable
Research on genetic profiling and its clinical significance using clinical specimens from cancer patients
JPRN-UMIN000049066ational Cancer Center Hospital East Department of Gastroenterology700
Recruiting
Not Applicable
Evaluation Study for its Clinical Utility of Gene Prognostic Signature MammaPrint for Early-Breast CancerBreast Cancer
JPRN-UMIN000002834Department of Breast and Endocrine Surjery, Juntendo University School of Medicine50